
Home » GLAXOSMITHKLINE REPORTS POSITIVE DRUG TRIAL RESULTS
GLAXOSMITHKLINE REPORTS POSITIVE DRUG TRIAL RESULTS
UK-based pharmaceutical major GlaxoSmithKline Plc Monday reported encouraging results of the phase III clinical trials of its experimental drug, eltrombopag. The drug was researched in collaboration with Ligand Pharmaceuticals.
Newratings
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
01Feb
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb